We are live on ! Find out more
PODD icon

Insulet

214 hedge funds and large institutions have $5.61B invested in Insulet in 2018 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 62 increasing their positions, 76 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

270% more call options, than puts

Call options by funds: $9.8M | Put options by funds: $2.65M

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

48% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 31

29% more capital invested

Capital invested by funds: $4.34B → $5.61B (+$1.27B)

5% more funds holding

Funds holding: 203214 (+11)

2.8% more ownership

Funds ownership: 108.08%110.88% (+2.8%)

18% less repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 76

Holders
214
Holders Change
+11
Holders Change %
+5.42%
% of All Funds
4.9%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
46
Increased
62
Reduced
76
Closed
31
Calls
$9.8M
Puts
$2.65M
Net Calls
+$7.16M
Net Calls Change
+$6.78M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$753M +$6.85M +88,138 +1%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$501M +$79.9M +1,028,748 +22%
Capital Research Global Investors
3
Capital Research Global Investors
California
$448M -$41.2M -529,945 -9%
Vanguard Group
4
Vanguard Group
Pennsylvania
$430M +$10.4M +133,970 +3%
Primecap Management
5
Primecap Management
California
$429M
BlackRock
6
BlackRock
New York
$348M +$10.7M +137,211 +4%
FCM
7
Frontier Capital Management
Massachusetts
$195M +$11.6M +149,857 +7%
FAM
8
Fred Alger Management
New York
$167M +$9.4M +121,049 +7%
ClearBridge Investments
9
ClearBridge Investments
New York
$146M -$21.9M -282,184 -14%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$124M +$6.79M +87,447 +7%
Lord, Abbett & Co
11
Lord, Abbett & Co
New Jersey
$105M +$2.64M +34,025 +3%
State Street
12
State Street
Massachusetts
$103M -$10.8M -138,884 -11%
CIP
13
Champlain Investment Partners
Vermont
$90.2M -$2.71M -34,935 -3%
Renaissance Technologies
14
Renaissance Technologies
New York
$86.5M +$26.1M +336,300 +51%
JP Morgan Chase
15
JP Morgan Chase
New York
$67M -$1.03M -13,298 -2%
Northern Trust
16
Northern Trust
Illinois
$65.8M -$177K -2,284 -0.3%
Wells Fargo
17
Wells Fargo
California
$64.7M -$428K -5,510 -0.7%
TI
18
Think Investments
California
$59.9M
Norges Bank
19
Norges Bank
Norway
$57M -$1.81M -23,300 -3%
O
20
OppenheimerFunds
New York
$54.2M +$29.9M +384,790 +160%
ACH
21
ArrowMark Colorado Holdings
Colorado
$54.2M +$11K +141 +0%
AAMU
22
AEGON Asset Management (UK)
United Kingdom
$50.5M +$26.8M +345,476 +146%
EAM
23
Eagle Asset Management
Florida
$47M +$42.1M +542,254 New
Geode Capital Management
24
Geode Capital Management
Massachusetts
$46.1M +$946K +12,180 +2%
Victory Capital Management
25
Victory Capital Management
Texas
$38M +$17.5M +225,230 +106%

PODD Hedge Fund Activity: Q1 2018 in Review

214 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q1 2018, worth a combined $5.61B — up 29% from $4.34B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new PODD positions and 31 closed out — a net gain of 15 holders — while 62 added to existing stakes and 76 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $79.9M. The largest seller was Millennium Management, cutting an estimated $51.7M.

  • 214 institutional investors held Insulet (PODD) as of Q1 2018, up from 203 in Q4 2017.
  • Funds reported $5.61B of Insulet stock for Q1 2018, up 29% quarter-over-quarter.
  • 46 funds opened new Insulet positions in Q1 2018 and 31 closed out, a net change of +15 holders.
  • The largest Insulet buyer in Q1 2018 was Wellington Management Group, an estimated $79.9M added.
  • The largest Insulet seller in Q1 2018 was Millennium Management, an estimated $51.7M sold.

Based on aggregated 13F filings for Q1 2018.